Reviewed by Dr. Arjun Mehta, PharmD — Head Pharmacist. Updated May 2025.
Typical onset
Main pathway
Lifelong therapy
Parkinson’s disease is a progressive movement disorder caused by loss of dopamine-producing neurons in the brain. Cardinal features are tremor at rest, stiffness, slowness of movement and postural instability. Treatment aims to replace or mimic the missing dopamine, and to delay disability.
Levodopa (combined with carbidopa) remains the most effective treatment for symptoms. It is usually started early — older ‘reserve levodopa for late’ thinking has been retired. Dopamine agonists, MAO-B inhibitors and COMT inhibitors are used alone or with levodopa to smooth out symptoms.
The gold-standard treatment. Most effective for motor symptoms. Doses adjusted as disease progresses.
Ropinirole, pramipexole. Useful in younger patients to delay levodopa. Watch for impulse-control side effects.
Selegiline, rasagiline. Mild effect, useful as monotherapy in early disease or as add-on.
Its effect remains, but treatment becomes less smooth (on-off effects, wearing off) as disease progresses. Adjusting timing and adding other drugs helps.
Up to 1 in 7 patients develop impulse-control problems (gambling, hypersexuality, compulsive shopping). Patients and families should be warned.
Yes — regular exercise (especially boxing-style, dance, or treadmill training) has measurable benefits on motor function and quality of life.

/our-pharmacists/arjun-mehta/ — Reviewed May 2025
This guide is reviewed every 12 months or sooner when clinical guidance changes. If you have a specific medical question, call our pharmacist team — we answer the phone, not a bot.